ADRB2基因多态性对1型糖尿病患者严重低血糖风险的影响
该研究纳入311例1型糖尿病患者,回顾性收集严重低血糖事件并检测ADRB2 Gly16Arg基因型。Arg16纯合子(AA)患者严重低血糖相对率为2.2(95%CI 1.3-3.6),在低血糖感知受损或无知觉者中AA基因型相对率达3.2(95%CI 1.7-6.0)。结论认为ADRB2多态性与1型糖尿病严重低血糖风险相关,尤其在低血糖感知受损者中。
要点
- ADRB2 Arg16纯合子(AA)患者严重低血糖相对率为2.2(95%CI 1.3-3.6)。
- 低血糖感知受损或无知觉者中,AA基因型相对率达3.2(95%CI 1.7-6.0)。
- 基因型与低血糖感知状态本身无关,差异不能用其他危险因素解释。
核心结论
- ADRB2基因多态性与1型糖尿病患者严重低血糖风险相关,尤其在低血糖感知受损者中。
研究设计与样本
- 队列研究,纳入311例1型糖尿病患者,通过经验证的问卷回顾性报告严重低血糖事件,并检测ADRB2基因型。
主要发现
- ADRB2 Gly16Arg基因型分布符合Hardy-Weinberg平衡。
- 所有基因型间严重低血糖发生率存在差异(P=0.01)。
- Arg16纯合子(AA;n=60)患者严重低血糖相对率为2.2(95%CI 1.3-3.6),对照为Gly16纯合子(GG;n=116;P=0.002)。
- 在低血糖感知受损或无知觉者(n=175)中,AA基因型(n=33)患者严重低血糖相对率为3.2(95%CI 1.7-6.0),对照为GG基因型(n=58;P<0.000)。
- 基因型与低血糖感知状态本身无关,差异不能用其他危险因素解释。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Severe hypoglycemic events are unevenly distributed in people with type 1 diabetes, making a genetic influence probable. Of the common adrenoceptor β-2 receptor gene (ADRB2) polymorphisms, the Arg16 allele is associated with receptor downregulation and reduced agonist-mediated endogenous glucose production. OBJECTIVE: We tested the hypothesis that the Arg16 variant is associated with severe hypoglycemia. METHOD: A cohort of 311 patients with type 1 diabetes reported severe hypoglycemic events retrospectively in a validated questionnaire. The patients were characterized by diabetes history, state of hypoglycemia awareness, C-peptide status, HbA1c, and ADRB2 genotype. RESULTS: The ADRB2 Gly16Arg genotype distribution was in Hardy-Weinberg equilibrium. The rate of severe hypoglycemia differed among all genotypes (P = 0.01). Patients homozygous for the Arg16 genotype (AA; n = 60) had a relative rate (RR) of severe hypoglycemia of 2.2 (95% CI, 1.3 to 3.6) compared with patients homozygous for the Gly16 genotype (GG; n = 116; P = 0.002). Among patients with impaired awareness or unawareness (n = 175), those with the AA genotype (n = 33) had an RR of severe hypoglycemia of 3.2 (95% CI, 1.7 to 6.0) compared with patients with the GG genotype (n = 58; P < 0.000). Genotype was not associated with state of hypoglycemia awareness per se, as assessed by any of three classification methods. The difference was not explained by other risk factors. CONCLUSION: Genetic polymorphism in ADRB2 is associated with risk of severe hypoglycemia in individuals with type 1 diabetes, especially in those with impaired hypoglycemia awareness.
引用
- Rokamp KZ, Olsen NV, Færch L, et al. Impact of Genetic Polymorphism in the β2-Receptor Gene on Risk of Severe Hypoglycemia in Patients With Type 1 Diabetes. J Clin Endocrinol Metab. 2018. PMID: 29757443. doi:10.1210/jc.2017-02739
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。